查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954674

全球病毒清除市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察、未來預測（2026-2034）

Viral Clearance Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 128 Pages | 商品交期: 請詢問到貨日

價格

病毒清除市場成長驅動因素

2025年全球病毒清除市場規模為8.341億美元，預計將從2026年的9.7165億美元成長到2034年的38.0475億美元，在預測期（2026-2034年）內年複合成長率高達18.60%。北美地區憑藉其成熟的生物技術生態系統和不斷成長的臨床試驗活動，在2025年佔據了37.50%的市場佔有率，成為市場主導者。

病毒清除檢測對於植物、動物或人源生物製品的研發和生產非常重要，因為這些產品極易受到病毒污染的影響。這些檢測可確保疫苗、重組蛋白、血液製品以及細胞和基因療法的安全性和純度。隨著全球疫苗年產量達到約50億劑，對病毒安全性檢測的需求持續成長。儘管新冠疫情封鎖期間市場成長放緩，但2021年的復甦得益於疫苗研發和臨床研究的增加。

市場動態

市場驅動因素

生物製藥研發投入增加

隨著心血管疾病、癌症和糖尿病等慢性疾病的日益增多，對生物製劑的需求也不斷成長。根據世界衛生組織統計，2020年全球有1,000萬人死於癌症。為了應對這項挑戰，製藥公司增加研發投入。例如，美國藥品研究與製造商協會（PhRMA）成員公司在2022年投入了1,023億美元研發。由於病毒清除是生物製藥產品核准的必要條件，研發投入的增加直接推動了相關服務的需求。

嚴格的監理要求

包括國際人用藥品註冊技術協調會（ICH）在內的全球監管機構已發布了針對生物技術產品病毒安全性評估的嚴格指南。符合新藥研究申請（IND）和生物製品許可申請（BLA）的提交標準，使得病毒清除檢測成為生物製品開發的關鍵環節，推動了市場成長。

市場趨勢

主要公司擴建設施

主要服務供應商擴大其病毒清除檢測設施，以滿足不斷成長的全球需求。例如，2022年9月，Merck KGaA在中國開設了一家病毒清除檢測中心，作為其生物製品檢測中心的一部分。同樣，WuXi Biologics和Texcell等公司也在擴大其檢測設施，以提升服務能力。這些擴建有助於製藥和生物技術公司更佳獲取檢測資源，並支持疫苗和先進療法的快速研發。

限制因子

先進技術成本高

病毒清除檢測需要先進的分析系統，例如色譜法和高效液相層析法（HPLC）。設備成本可能在3萬美元到10萬美元之間，對小型企業來說是一筆不小的開銷。此外，對高技能科學家的競爭推高了營運成本，限制了小型供應商的採用。

市場區隔分析

依方法劃分

該市場依方法分為三類：病毒去除、病毒滅活和病毒檢測。

到2026年，病毒去除領域將成為市場成長的主要驅動力。這得益於疫苗和生物製劑需求的成長以及研發投入的強勁。色譜和過濾等技術因其高效性而廣泛採用。

病毒滅活領域預計將保持穩定成長，這得益於血漿蛋白和基因治療產品獲準數量的增加。另一方面，包括PCR和次世代定序（NGS）在內的病毒檢測方法預計將以相當可觀的年複合成長率成長，因為它們在識別病毒污染物方面發揮著非常重要的作用。

依應用領域劃分

依應用領域劃分，市場包括疫苗、血液及血液製品、重組蛋白、細胞及基因治療產品等產品。

預計到2026年，疫苗領域將成為市場成長的主要驅動力，這主要得益於疫苗接種率的提高以及人們對傳染病和慢性病防護需求的不斷成長。例如，2022年全球麻疹疫苗接種率達83%。

預計血液及血液製品領域將顯著成長，這主要得益於全球每年約1.185億份的捐血量。由於先進療法在罕見疾病和慢性病治療中的應用日益廣泛，細胞和基因治療領域預計將以最高的年複合成長率成長。

依最終使用者劃分

該市場依最終用戶細分為製藥和生物技術行業、合約研究組織（CRO）、學術和研究機構以及其他。

2026年，製藥和生技產業將成為市場的主要驅動力。這主要是由於生物製品生產中強制性的病毒安全性檢測。由於檢測服務外包的增加，CRO預計將顯著成長。受藥物研發計畫的擴展推動，學術和研究機構預計也將強勁成長。

區域洞察

北美

2025年，北美市場規模將達到3.127億美元，憑藉強大的製藥生產能力和不斷成長的臨床試驗，繼續保持領先地位。在美國，註冊臨床試驗的數量從2010年的7462項增加到2022年的9901項，這增強了對病毒清除服務的需求。

歐洲

歐洲是第二大市場，這得益於其強大的生物技術基礎和不斷成長的研發投入。例如，CRISPR Therapeutics等公司在2022年投資了4.616億美元用於研發，推動了該地區的擴張。

亞太地區

由於仿製藥產量增加、醫學研究經費投入增加以及合約研究組織（CRO）的擴張，亞太地區預計將經歷快速成長。中國和日本加強其國內生物製藥產能，推動對病毒清除服務的需求。

由於醫療支出增加和生物製品應用範圍擴大，拉丁美洲和中東及非洲地區預計將實現溫和成長。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機會

第4章 主要考察

  • 技術進步
  • 主要行業趨勢
  • 監理環境
  • 主要產業趨勢：併購、業務合作關係等
  • 新冠疫情對市場的影響

第5章 全球病毒清除市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依方法劃分
    • 病毒去除法
      • 色譜法
      • 過濾法
      • 沉澱法
    • 病毒滅活方法
      • pH調節法
      • 溶劑/洗滌劑法（S/D）
      • 巴氏殺菌法
      • 乾熱法
      • 其他
    • 病毒檢測方法
      • 次世代定序（NGS）
      • 聚合酶鍊式反應（PCR）
      • 體內檢測
      • 體外檢測檢測
      • 其他
  • 市場分析、洞察與預測：依應用領域劃分
    • 血液及血液製品
    • 重組蛋白
    • 細胞及基因治療產品
    • 疫苗
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 製藥及生技產業
    • 學術及研究機構
    • 合約研究組織（CRO）
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東及非洲

第6章 北美病毒清除市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第7章 歐洲病毒清除市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 其他歐洲地區

第8章 亞太地區病毒清除市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞亞洲
    • 其他亞太地區

第9章 拉丁美洲病毒清除市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章 中東與非洲病毒清除市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市場佔有率分析（2025）
  • 公司簡介
    • Merck KGaA
    • Wuxi Biologics
    • Charles River Laboratories
    • Texcell
    • Vironova
    • Kedrion
    • Clean Cells
    • ViruSure GmbH
    • Sartorius AG
    • Syngene International Limited
    • Microbiologics
Product Code: FBI105611

Growth Factors of viral clearance Market

The global viral clearance market size was valued at USD 834.1 million in 2025 and is projected to grow from USD 971.65 million in 2026 to USD 3,804.75 million by 2034, exhibiting a strong CAGR of 18.60% during the forecast period (2026-2034). North America dominated the market with a 37.50% share in 2025, supported by a well-established biotechnology ecosystem and rising clinical trial activity.

Viral clearance studies are critical in the development and manufacturing of biologics derived from plants, animals, or humans, as these products are highly susceptible to viral contamination. These studies ensure the safety and purity of vaccines, recombinant proteins, blood products, and cell & gene therapies. With global vaccine production reaching nearly 5.0 billion doses annually, the demand for viral safety testing continues to increase. Although the market witnessed slower growth during the COVID-19 lockdown phase, recovery in 2021 was driven by increased vaccine development and clinical research.

Market Dynamics

Market Drivers

Rising Biopharmaceutical R&D Expenditure

The growing burden of chronic diseases such as cardiovascular disorders, cancer, and diabetes has intensified the need for biologics. According to WHO, cancer accounted for 10 million deaths globally in 2020. To address this, pharmaceutical companies are increasing R&D spending. For instance, PhRMA member companies invested USD 102.3 billion in R&D in 2022. As viral clearance is mandatory for biologics approval, increasing R&D directly fuels demand for these services.

Stringent Regulatory Requirements

Global regulatory bodies, including the International Council for Harmonisation (ICH), have issued strict guidelines on viral safety evaluation for biotechnology products. Compliance with IND and BLA submission standards has made viral clearance testing an essential part of biologics development, thereby driving market growth.

Market Trends

Facility Expansion by Key Players

Leading service providers are expanding viral clearance laboratories to meet growing global demand. For example, in September 2022, Merck KGaA opened a viral clearance laboratory in China as part of its Biologics Testing Center. Similarly, companies such as WuXi Biologics and Texcell have expanded testing facilities to enhance service capabilities. These expansions improve accessibility for pharmaceutical and biotech firms and support the rapid development of vaccines and advanced therapies.

Restraining Factors

High Cost of Advanced Technologies

Viral clearance studies require sophisticated analytical systems such as chromatography and high-performance liquid chromatography (HPLC). Equipment costs can range from USD 30,000 to USD 100,000, creating financial barriers for smaller firms. Additionally, competition for highly skilled scientists increases operational costs, limiting adoption among small-scale providers.

Segmentation Analysis

By Method

The market is segmented into viral removal, viral inactivation, and viral detection.

The viral removal method segment dominated in 2026, driven by increasing demand for vaccines and biologics and strong R&D investments. Techniques such as chromatography and filtration are widely used due to their efficiency.

The viral inactivation segment is projected to grow steadily, supported by rising approvals of plasma proteins and gene therapy products. Meanwhile, viral detection methods, including PCR and next-generation sequencing (NGS), are expected to grow at a considerable CAGR due to their essential role in identifying viral contaminants.

By Application

Based on application, the market includes vaccines, blood & blood products, recombinant proteins, cellular & gene therapy products, and others.

The vaccines segment dominated in 2026, fueled by growing immunization coverage and demand for protection against infectious and chronic diseases. For example, global measles vaccine coverage increased to 83% in 2022.

The blood & blood products segment is anticipated to expand substantially, supported by approximately 118.5 million blood donations collected worldwide annually. The cellular & gene therapy segment is expected to grow at the highest CAGR due to increasing use of advanced therapies in treating rare and chronic conditions.

By End-user

The market is segmented into pharmaceutical & biotech industry, CROs, academic research institutes, and others.

The pharmaceutical & biotech industry segment dominated in 2026, as viral safety testing is mandatory for biologics manufacturing. CROs are projected to grow significantly due to increased outsourcing of testing services. Academic and research institutes are also expected to witness strong growth, driven by expanding drug discovery research initiatives.

Regional Insights

North America

North America accounted for USD 312.7 million in 2025, maintaining leadership due to strong pharmaceutical manufacturing capacity and increasing clinical trials. The U.S. recorded a rise in registered clinical trials from 7,462 in 2010 to 9,901 in 2022, strengthening demand for viral clearance services.

Europe

Europe is the second-largest market, supported by a strong biotechnology foundation and rising R&D spending. Companies such as CRISPR Therapeutics invested USD 461.6 million in R&D in 2022, contributing to regional expansion.

Asia Pacific

Asia Pacific is projected to grow rapidly due to increased generics manufacturing, funding for medical research, and expansion of CROs. China and Japan are strengthening domestic biopharmaceutical production capabilities, boosting demand for viral clearance services.

Latin America and the Middle East & Africa are expected to witness gradual growth due to rising healthcare expenditure and biologics adoption.

Competitive Landscape

Key market players include Merck KGaA, Charles River Laboratories, WuXi Biologics, Texcell, Sartorius AG, Kedrion, Clean Cells, ViruSure GmbH, and Syngene International. These companies focus on facility expansion, acquisitions, and service portfolio enhancement to strengthen market presence.

Recent developments include:

  • June 2023: Texcell expanded its viral clearance facility in the U.S.
  • December 2022: WuXi Biologics opened a Biosafety Testing Center in Shanghai.
  • December 2021: ViruSure acquired Bionique Testing Laboratories to enhance service offerings.

Conclusion

The global viral clearance market is poised for robust expansion, growing from USD 834.1 million in 2025 to USD 971.65 million in 2026, and projected to reach USD 3,804.75 million by 2034, at a remarkable CAGR of 18.60%. Increasing biologics development, stringent regulatory requirements, expanding R&D investments, and facility expansions by key players are primary growth drivers. Despite high technology costs and talent shortages, the rising global demand for safe and effective biopharmaceuticals will continue to propel long-term market growth.

Segmentation By Method

  • Viral Removal Method
    • Chromatography
    • Filtration
    • Precipitation
  • Viral Inactivation Method
    • pH Modification
    • Solvent Detergent (S/D)
    • Pasteurization
    • Dry Heat
    • Others
  • Viral Detection Method
    • Next Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • In vivo Assay
    • In vitro Assay
    • Others

By Application

  • Blood and Blood Products
  • Recombinant Proteins
  • Cellular & Gene Therapy Products
  • Vaccines
  • Others

By End-user

  • Pharmaceutical and Biotech Industry
  • Academic Research Institutes
  • CROs
  • Others

By Geography

  • North America (By Method, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Method, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Method, Application, End-user, and Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Method, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Method, Application, End-user, and Country/Sub-region)
    • South Africa
    • GCC
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Technological Advancements
  • 4.2. Key Industry Trends
  • 4.3. Regulatory Scenario
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Method
    • 5.1.1. Viral Removal Method
      • 5.1.1.1. Chromatography
      • 5.1.1.2. Filtration
      • 5.1.1.3. Precipitation
    • 5.1.2. Viral Inactivation Method
      • 5.1.2.1. pH Modification
      • 5.1.2.2. Solvent Detergent (S/D)
      • 5.1.2.3. Pasteurization
      • 5.1.2.4. Dry Heat
      • 5.1.2.5. Others
    • 5.1.3. Viral Detection Method
      • 5.1.3.1. Next Generation Sequencing (NGS)
      • 5.1.3.2. Polymerase Chain Reaction (PCR)
      • 5.1.3.3. In vivo Assay
      • 5.1.3.4. In vitro Assay
      • 5.1.3.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Applications
    • 5.2.1. Blood and Blood Products
    • 5.2.2. Recombinant Proteins
    • 5.2.3. Cellular & Gene Therapy Products
    • 5.2.4. Vaccines
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical and Biotech Industry
    • 5.3.2. Academic Research Institutes
    • 5.3.3. CROs
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Geography
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Method
    • 6.1.1. Viral Removal Method
      • 6.1.1.1. Chromatography
      • 6.1.1.2. Filtration
      • 6.1.1.3. Precipitation
    • 6.1.2. Viral Inactivation Method
      • 6.1.2.1. pH Modification
      • 6.1.2.2. Solvent Detergent (S/D)
      • 6.1.2.3. Pasteurization
      • 6.1.2.4. Dry Heat
      • 6.1.2.5. Others
    • 6.1.3. Viral Detection Method
      • 6.1.3.1. Next Generation Sequencing (NGS)
      • 6.1.3.2. Polymerase Chain Reaction (PCR)
      • 6.1.3.3. In vivo Assay
      • 6.1.3.4. In vitro Assay
      • 6.1.3.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Applications
    • 6.2.1. Blood and Blood Products
    • 6.2.2. Recombinant Proteins
    • 6.2.3. Cellular & Gene Therapy Products
    • 6.2.4. Vaccines
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical and Biotech Industry
    • 6.3.2. Academic Research Institutes
    • 6.3.3. CROs
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Method
    • 7.1.1. Viral Removal Method
      • 7.1.1.1. Chromatography
      • 7.1.1.2. Filtration
      • 7.1.1.3. Precipitation
    • 7.1.2. Viral Inactivation Method
      • 7.1.2.1. pH Modification
      • 7.1.2.2. Solvent Detergent (S/D)
      • 7.1.2.3. Pasteurization
      • 7.1.2.4. Dry Heat
      • 7.1.2.5. Others
    • 7.1.3. Viral Detection Method
      • 7.1.3.1. Next Generation Sequencing (NGS)
      • 7.1.3.2. Polymerase Chain Reaction (PCR)
      • 7.1.3.3. In vivo Assay
      • 7.1.3.4. In vitro Assay
      • 7.1.3.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Applications
    • 7.2.1. Blood and Blood Products
    • 7.2.2. Recombinant Proteins
    • 7.2.3. Cellular & Gene Therapy Products
    • 7.2.4. Vaccines
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical and Biotech Industry
    • 7.3.2. Academic Research Institutes
    • 7.3.3. CROs
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Method
    • 8.1.1. Viral Removal Method
      • 8.1.1.1. Chromatography
      • 8.1.1.2. Filtration
      • 8.1.1.3. Precipitation
    • 8.1.2. Viral Inactivation Method
      • 8.1.2.1. pH Modification
      • 8.1.2.2. Solvent Detergent (S/D)
      • 8.1.2.3. Pasteurization
      • 8.1.2.4. Dry Heat
      • 8.1.2.5. Others
    • 8.1.3. Viral Detection Method
      • 8.1.3.1. Next Generation Sequencing (NGS)
      • 8.1.3.2. Polymerase Chain Reaction (PCR)
      • 8.1.3.3. In vivo Assay
      • 8.1.3.4. In vitro Assay
      • 8.1.3.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Applications
    • 8.2.1. Blood and Blood Products
    • 8.2.2. Recombinant Proteins
    • 8.2.3. Cellular & Gene Therapy Products
    • 8.2.4. Vaccines
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical and Biotech Industry
    • 8.3.2. Academic Research Institutes
    • 8.3.3. CROs
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Method
    • 9.1.1. Viral Removal Method
      • 9.1.1.1. Chromatography
      • 9.1.1.2. Filtration
      • 9.1.1.3. Precipitation
    • 9.1.2. Viral Inactivation Method
      • 9.1.2.1. pH Modification
      • 9.1.2.2. Solvent Detergent (S/D)
      • 9.1.2.3. Pasteurization
      • 9.1.2.4. Dry Heat
      • 9.1.2.5. Others
    • 9.1.3. Viral Detection Method
      • 9.1.3.1. Next Generation Sequencing (NGS)
      • 9.1.3.2. Polymerase Chain Reaction (PCR)
      • 9.1.3.3. In vivo Assay
      • 9.1.3.4. In vitro Assay
      • 9.1.3.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Applications
    • 9.2.1. Blood and Blood Products
    • 9.2.2. Recombinant Proteins
    • 9.2.3. Cellular & Gene Therapy Products
    • 9.2.4. Vaccines
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical and Biotech Industry
    • 9.3.2. Academic Research Institutes
    • 9.3.3. CROs
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Viral Clearance Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Method
    • 10.1.1. Viral Removal Method
      • 10.1.1.1. Chromatography
      • 10.1.1.2. Filtration
      • 10.1.1.3. Precipitation
    • 10.1.2. Viral Inactivation Method
      • 10.1.2.1. pH Modification
      • 10.1.2.2. Solvent Detergent (S/D)
      • 10.1.2.3. Pasteurization
      • 10.1.2.4. Dry Heat
      • 10.1.2.5. Others
    • 10.1.3. Viral Detection Method
      • 10.1.3.1. Next Generation Sequencing (NGS)
      • 10.1.3.2. Polymerase Chain Reaction (PCR)
      • 10.1.3.3. In vivo Assay
      • 10.1.3.4. In vitro Assay
      • 10.1.3.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Applications
    • 10.2.1. Blood and Blood Products
    • 10.2.2. Recombinant Proteins
    • 10.2.3. Cellular & Gene Therapy Products
    • 10.2.4. Vaccines
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Pharmaceutical and Biotech Industry
    • 10.3.2. Academic Research Institutes
    • 10.3.3. CROs
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Merck KGaA
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Wuxi Biologics
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Charles River Laboratories
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Texcell
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Vironova
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Kedrion
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Clean Cells
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. ViruSure GmbH
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Sartorius AG
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Syngene International Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. Microbiologics
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & Services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 2: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 3: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 4: Global Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 5: Global Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 6: Global Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 7: Global Viral Clearance Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 8: North America Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 9: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 10: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 11: North America Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 12: North America Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 13: North America Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 14: North America Viral Clearance Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 15: Europe Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 16: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 17: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 18: Europe Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 19: Europe Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 20: Europe Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 21: Europe Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 22: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 23: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 24: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 25: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 26: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 27: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 30: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 31: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 32: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 33: Latin America Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 34: Latin America Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 35: Latin America Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Method, 2021-2034
  • Table 37: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Removal Method, 2021-2034
  • Table 38: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Inactivation Method, 2021-2034
  • Table 39: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Viral Detection Method, 2021-2034
  • Table 40: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by Application, 2021-2034
  • Table 41: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa Viral Clearance Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Viral Clearance Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 01: Global Viral Clearance Market Value Share (%), By Method, 2025 & 2034
  • Figure 02: Global Viral Clearance Market Value Share (%), By Application, 2025 & 2034
  • Figure 03: Global Viral Clearance Market Value Share (%), By End-user, 2025 & 2034
  • Figure 04: Global Viral Clearance Market Value Share (%), By Region, 2025 & 2034
  • Figure 05: North America Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 06: North America Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 07: North America Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 08: North America Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 09: North America Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 10: North America Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 11: North America Viral Clearance Market Value (USD million), By Region, 2025 & 2034
  • Figure 12: North America Viral Clearance Market Value Share (%), By Region, 2025
  • Figure 13: Europe Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 14: Europe Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 15: Europe Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 16: Europe Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 17: Europe Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 18: Europe Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 19: Europe Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 20: Europe Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 21: Asia Pacific Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 22: Asia Pacific Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 23: Asia Pacific Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 24: Asia Pacific Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 25: Asia Pacific Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 26: Asia Pacific Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 27: Asia Pacific Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 28: Asia Pacific Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 29: Latin America Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 30: Latin America Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 31: Latin America Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 32: Latin America Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 33: Latin America Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 34: Latin America Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 35: Latin America Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 36: Latin America Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 37: Middle East & Africa Viral Clearance Market Value (USD million), By Method, 2025 & 2034
  • Figure 38: Middle East & Africa Viral Clearance Market Value Share (%), By Method, 2025
  • Figure 39: Middle East & Africa Viral Clearance Market Value (USD million), By Application, 2025 & 2034
  • Figure 40: Middle East & Africa Viral Clearance Market Value Share (%), By Application, 2025
  • Figure 41: Middle East & Africa Viral Clearance Market Value (USD million), By End-user, 2025 & 2034
  • Figure 42: Middle East & Africa Viral Clearance Market Value Share (%), By End-user, 2025
  • Figure 43: Middle East & Africa Viral Clearance Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 44: Middle East & Africa Viral Clearance Market Value Share (%), By Country/Sub-region, 2025
  • Figure 45: Global Viral Clearance Market Share (%), By Company, 2025